Pfizer Products Inc.
68Patents
12Active
68Granted
39Portfolio score
Filing activity: Mar 25, 1999 → Jan 6, 2012 · 11 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7803832B2 | N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides | Chemistry; Metallurgy | 81 | Active |
| US6476040B1 | Processes and intermediates for preparing anti-cancer compounds | Emerging Cross-Sectional Technologies | 69 | Expired |
| US6846477B2 | One dose vaccination with Mycoplasma hyopneumoniae | Emerging Cross-Sectional Technologies | 57 | Expired |
| US6770288B2 | Drug delivery system | Human Necessities | 50 | Expired |
| US6852719B2 | Glucocorticoid receptor modulators | Chemistry; Metallurgy | 33 | Expired |
| US6720336B2 | 4,4-biarylpiperidine derivatives | Chemistry; Metallurgy | 33 | Expired |
| US7030242B2 | Selective inhibition of aggrecanase in osteoarthritis treatment | Chemistry; Metallurgy | 31 | Expired |
| US7067664B1 | Corticotropin releasing factor antagonists | Chemistry; Metallurgy | 30 | Expired |
| US6589947B1 | Use of corticotropin releasing factor antagonists and related compositions | Human Necessities | 21 | Expired |
| US6558435B2 | Reactive crystallization method to improve particle size | Performing Operations; Transporting | 21 | Expired |
| US6858624B2 | Aryl fused azapolycyclic compounds | Chemistry; Metallurgy | 18 | Expired |
| US6617440B1 | Myostatin regulatory region, nucleotide sequence determination and methods for its use | Human Necessities | 15 | Expired |
| US6733754B2 | Adjuvants for use in vaccines | Emerging Cross-Sectional Technologies | 15 | Expired |
| US7417041B2 | Imidazopyrimidines as transforming growth factor (TGF) inhibitors | Chemistry; Metallurgy | 15 | Expired |
| US7138406B2 | Modulators of the glucocorticoid receptor | Chemistry; Metallurgy | 13 | Expired |
| US7687507B2 | Pyrrolo[2,3-d]pyrimidine compounds | Human Necessities | 12 | Expired |
| US6605696B1 | Lawsonia intracellularis proteins, and related methods and materials | Chemistry; Metallurgy | 11 | Expired |
| US7354941B2 | Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes | Chemistry; Metallurgy | 10 | Expired |
| US7378408B2 | Methods of treatment and formulations of cephalosporin | Human Necessities | 8 | Expired |
| US6927219B2 | N-alkyl-adamantyl triazinyl benzamide derivatives | Human Necessities | 8 | Expired |
| US6887472B2 | Anti-IgE vaccines | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7687533B2 | N-(1-arylpyrazol-4l) sulfonamides and their use as parasiticides | Chemistry; Metallurgy | 7 | Active |
| US6713071B1 | Proteins from actinobacillus pleuropneumoniae | Human Necessities | 7 | Expired |
| US7151110B2 | Pyrazole compounds as transforming growth factor (TGF) inhibitors | Chemistry; Metallurgy | 7 | Expired |
| US7153872B2 | Imidazole compounds as transforming growth factor (TGF) inhibitors | Chemistry; Metallurgy | 6 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.